The International Society for Stem Cell Application (ISSCA) is excited to announce the much-anticipated World Congress 2023, further establishing its role as the primary global hub for regenerative medicine. The event is set to occur from November 10 to 12, 2023, at the esteemed Crowne Plaza Istanbul Florya Hotel in Istanbul, Turkey. Drawing on the remarkable achievements of the previous conference held at the Radisson Blu Hotel on September 23 to 26, 2022, ISSCA is prepared to exceed all predictions with this highly anticipated World Congress.

During the three-day congress, prominent physicians from across the globe will come together, offering an extensive agenda of presentations and interactive sessions. “Our ISSCA Congresses once more provide a great opportunity to disseminate this information to the physicians who need it most, and we plan to organize as many as we can before the end of the year,” says ISSCA Managing Director and CEO of Global Stem Cells Group Benito Novas about the upcoming congress.

Participants can anticipate captivating workshops, including those focused on aesthetic and clinical applications, aimed at delving into the most recent advancements within the rapidly evolving field of regenerative medicine.

In a full schedule of lectures, the congress will shed light on significant subjects such as molecular biology, innovative treatment approaches in surgical and cosmetic domains, and the latest cutting-edge technologies that have emerged in the field. In addition, the congress will explore the legal framework encompassing regenerative medicine practices on a global scale, acknowledging the varying degrees of involvement by various national governments.

This conference demonstrates ISSCA’s dedication to facilitating a transformative change from traditional healthcare methods to regenerative medicine while showcasing the most recent innovative discoveries and progress in all aspects of stem cell research.

The Crowne Plaza Istanbul Florya Hotel, known for its modern facilities and ideal location in Istanbul, Turkey, will serve as the prestigious venue for this highly anticipated event. Its comfortable and conducive environment provides the optimum platform for attendees to exchange ideas and establish new partnerships.

The ISSCA World Congress 2023 in Istanbul is a must-attend event for anyone interested in regenerative medicine. With a focus on innovation, collaboration, and knowledge exchange, the congress promises to be a transformative experience for all attendees. Whether you are a scientist, physician, or healthcare professional, this event offers an opportunity to gain valuable insights and forge new connections with like-minded individuals from around the world.

For more information about the November 10 to 12 ISSCA World Congress 2023, please visit our official website today.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians who aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through advancements made in the specialty of regenerative medicine.

The mission of the International Stem Cell Certification Agency (ISSCA) is to establish itself as a global leader in regenerative medicine certification, education, research, and training.

ISSCA provides certification training in cities worldwide because it recognizes the importance of standards and certifications in regenerative medicine as a medical specialty. To help more people, both locally and globally, as the demand for more doctors interested in and comfortable with regenerative medicine surges. ISSCA’s mission is to advance quality and uniformity in regenerative medicine worldwide.

About Global Stem Cells Group:

The Global Stem Cell Group is a family of several companies focused on stem cell medicine and research. The company uses its network to bring leadership in regenerative medicine training, research, and patient applications.

GSCG’s mission is to allow physicians to present the benefits of stem cell medicine to patients worldwide. The company also partners with policymakers, educators, and regulators to promote regenerative medicine.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV.

To learn more about Global Stem Cells Group, Inc.’s companies visit our website or call +1 305 560 5331

Safe Harbor Statement:

Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Previous Post
Global Stem Cells Group Announces Opening of New Research Facility at Marmara University’s Main Campus in Istanbul, Turkey
Next Post
ISSCA launched its first regenerative medicine training in Hormonal Modulation and Gynecology

Latest posts